Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Drazner

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
JAMA Cardiology|November 15, 2018
Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart StudyAya J Alame, Sonia Garg, Julia Kozlitina, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 11, 2018
Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation)Pearlie P Chong, Dagny Teiber, Bonnie C Prokesch, et al.
The American Journal of Cardiology|January 13, 2004
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fractionJ Eduardo Rame, Marlon Ramilo, Nali Spencer, et al.
American Heart Journal|November 4, 2004
Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trialSandeep R Das, Mark H Drazner, Clyde W Yancy, et al.
Hypertension (Dallas, Tex. : 1979)|February 14, 2007
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterloadJ Eduardo Rame, Mark H Drazner, Wendy Post, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2007
Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and functionTorbjørn Omland, Mark H Drazner, Thor Ueland, et al.
European Journal of Heart Failure|March 2, 2018
Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HFJustin L Grodin, Spencer Carter, Bradley A Bart, et al.
Journal of the American Heart Association|November 1, 2018
Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT TrialAmbarish Pandey, Jarett D Berry, Mark H Drazner, et al.
The American Journal of Cardiology|July 2, 2023
Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection FractionJonathan Gordon, Katherine C Michelis, Ambarish Pandey, et al.
Journal of Cardiac Failure|November 22, 2024
ExCITe: A Narrative Review of Motivating Factors for Residency and Fellowship Selection to Provide Insights Regarding the Waning Interest in Advanced Heart Failure and Transplant Cardiology TrainingEdan Zitelny, Mark H Drazner, Jonathan Davis, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
JAMA Cardiology|November 15, 2018
Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart StudyAya J Alame, Sonia Garg, Julia Kozlitina, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 11, 2018
Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation)Pearlie P Chong, Dagny Teiber, Bonnie C Prokesch, et al.
The American Journal of Cardiology|January 13, 2004
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fractionJ Eduardo Rame, Marlon Ramilo, Nali Spencer, et al.
American Heart Journal|November 4, 2004
Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trialSandeep R Das, Mark H Drazner, Clyde W Yancy, et al.
Hypertension (Dallas, Tex. : 1979)|February 14, 2007
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterloadJ Eduardo Rame, Mark H Drazner, Wendy Post, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2007
Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and functionTorbjørn Omland, Mark H Drazner, Thor Ueland, et al.
European Journal of Heart Failure|March 2, 2018
Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HFJustin L Grodin, Spencer Carter, Bradley A Bart, et al.
Journal of the American Heart Association|November 1, 2018
Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT TrialAmbarish Pandey, Jarett D Berry, Mark H Drazner, et al.
The American Journal of Cardiology|July 2, 2023
Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection FractionJonathan Gordon, Katherine C Michelis, Ambarish Pandey, et al.
Journal of Cardiac Failure|November 22, 2024
ExCITe: A Narrative Review of Motivating Factors for Residency and Fellowship Selection to Provide Insights Regarding the Waning Interest in Advanced Heart Failure and Transplant Cardiology TrainingEdan Zitelny, Mark H Drazner, Jonathan Davis, et al.
Pageof 29